Matches in Nanopublications for { ?s ?p "[These results suggest that systemic delivery and sustained production of endostatin and soluble VEGFR2 can slow intracranial glial tumor growth by both reducing cell proliferation and increasing tumor apoptosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP449420.RAJ73JDTNvJZXGwakepJarT70_a9d_OpfGD82e2IAZxkI130_assertion description "[These results suggest that systemic delivery and sustained production of endostatin and soluble VEGFR2 can slow intracranial glial tumor growth by both reducing cell proliferation and increasing tumor apoptosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP449420.RAJ73JDTNvJZXGwakepJarT70_a9d_OpfGD82e2IAZxkI130_provenance.
- assertion description "[These results suggest that systemic delivery and sustained production of endostatin and soluble VEGFR2 can slow intracranial glial tumor growth by both reducing cell proliferation and increasing tumor apoptosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[These results suggest that systemic delivery and sustained production of endostatin and soluble VEGFR2 can slow intracranial glial tumor growth by both reducing cell proliferation and increasing tumor apoptosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP523627.RAMHQhmr-Nhh4otiZaGrfpwQi1yYiXBJyrdUY6Qp24bRU130_assertion description "[These results suggest that systemic delivery and sustained production of endostatin and soluble VEGFR2 can slow intracranial glial tumor growth by both reducing cell proliferation and increasing tumor apoptosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP523627.RAMHQhmr-Nhh4otiZaGrfpwQi1yYiXBJyrdUY6Qp24bRU130_provenance.
- NP950000.RAwB62suj9y1-325xvsoU7cBosfrXpOZPKav1N-W-YGVM130_assertion description "[These results suggest that systemic delivery and sustained production of endostatin and soluble VEGFR2 can slow intracranial glial tumor growth by both reducing cell proliferation and increasing tumor apoptosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP950000.RAwB62suj9y1-325xvsoU7cBosfrXpOZPKav1N-W-YGVM130_provenance.
- NP668627.RAGHzA6-WG_P9MwCkDwf57Kqv-q77PZFkQlLGmCnPKrb8130_assertion description "[These results suggest that systemic delivery and sustained production of endostatin and soluble VEGFR2 can slow intracranial glial tumor growth by both reducing cell proliferation and increasing tumor apoptosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP668627.RAGHzA6-WG_P9MwCkDwf57Kqv-q77PZFkQlLGmCnPKrb8130_provenance.
- NP668628.RA8aXFeAuHZnibnXTtxq--rNsh4RVZfLMPCbHy7R4RxqY130_assertion description "[These results suggest that systemic delivery and sustained production of endostatin and soluble VEGFR2 can slow intracranial glial tumor growth by both reducing cell proliferation and increasing tumor apoptosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP668628.RA8aXFeAuHZnibnXTtxq--rNsh4RVZfLMPCbHy7R4RxqY130_provenance.